News

COVID-19 corporate statement (17/03/2020)

In order to comply with Real Decreto 463/2020, March 14, declaring the state of alarm for the management of the health crisis situation caused by COVID-19, MAYMÓ Group has established an action plan since yesterday, March 16, 2020, thanks to which all measures requested by the authorities are being implemented. Due to the speed of events, a crisis committee is in charge of reviewing the situation daily.

At the 44th ASESCU Symposium

The 44º ASESCU Symposium (Spanish Rabbit Association) has been organized this year in Aranda de Duero (Burgos) June 5-6.

Launch of Neoiven in different EU countries

Neoiven 500.000 UI/g is the new oral neomycin from Iven for the international market. It has been recently authorized in seven EU member countries. Its launch is imminent in several markets.